Pharmaceutical Industry News
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US
Lupin and Granules India are recalling close to 9.71 lakh bottles of generic diabetes drug in the US due to the possibility of the affected lot containing cancer-causing nitrosodimethylamine (NDMA) above the acceptable intake limit
Clean Rooms | 27/07/2020 | By Darshana | 121
Lupin?s Pithampur Facilities Complete Successful UK MHRA Inspection
Pharma major Lupin Limited (Lupin) today announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK)
Clean Rooms | 08/05/2020 | By Darshana | 169
Karnataka forms expert committee to study epidemiology of COVID-19 & assess infection transmission
Karnataka has now constituted a committee of experts to look into the interventions to be taken to tackle COVID-19. The state as on Monday reported 237 cases, 8 fatalities and 60 discharges
Clean Rooms | 14/04/2020 | By Darshana | 133
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy